284 is the total number of securities SILVERARC CAPITAL MANAGEMENT, LLC has owned. The longest SILVERARC CAPITAL MANAGEMENT, LLC has owned a single stock is 12 quarters.
| Period | Weighting | Quarter | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| ITCI | INTRA-CELLULAR THERAPI... | 12 | 12 | 2.06% | 3.50% | 7.82% | Q4 2020 | Q3 2023 | 12 |
| IMGN | IMMUNOGEN INC | 12 | 12 | 0.24% | 2.71% | 8.29% | Q4 2020 | Q3 2023 | 12 |
| MORF | Morphic Holding Inc | 12 | 12 | 0.80% | 2.32% | 4.47% | Q4 2020 | Q3 2023 | 12 |
| COGT | UNUM THERAPEUTICS INC | 12 | 12 | 0.58% | 1.96% | 3.22% | Q4 2020 | Q3 2023 | 12 |
| INSM | INSMED INC | 12 | 12 | 0.71% | 1.73% | 3.54% | Q4 2020 | Q3 2023 | 12 |
| UTHR | UNITED THERAPEUTICS CO... | 12 | 12 | 0.47% | 1.33% | 2.21% | Q4 2020 | Q3 2023 | 12 |
| MRUS | MERUS N V | 11 | 11 | 1.22% | 3.43% | 5.08% | Q1 2021 | Q3 2023 | 11 |
| VCYT | VERACYTE INC | 11 | 11 | 1.36% | 2.96% | 4.86% | Q1 2021 | Q3 2023 | 11 |
| EVGN | EVOGENE LTD | 9 | 2 | 0.03% | 0.42% | 1.64% | Q4 2020 | Q3 2023 | 11 |
| CGEN | COMPUGEN LTD | 7 | 4 | 0.06% | 0.37% | 1.06% | Q4 2020 | Q3 2023 | 11 |
| MRTX | MIRATI THERAPEUTICS INC | 8 | 2 | 0.24% | 2.02% | 4.60% | Q4 2020 | Q3 2023 | 10 |
| ACRS | ACLARIS THERAPEUTICS INC | 10 | 10 | 0.70% | 1.98% | 4.63% | Q1 2021 | Q2 2023 | 10 |
| CERS | CERUS CORP | 10 | 10 | 0.24% | 1.84% | 3.41% | Q2 2021 | Q3 2023 | 10 |
| IMTX | IMMATICS N.V | 10 | 10 | 0.11% | 1.21% | 3.22% | Q1 2021 | Q2 2023 | 10 |
| BIIB | BIOGEN INC | 4 | 2 | 0.10% | 1.14% | 2.37% | Q4 2020 | Q3 2023 | 10 |
| VRTX | VERTEX PHARMACEUTICALS... | 8 | 2 | 0.44% | 1.04% | 1.71% | Q4 2020 | Q3 2023 | 10 |
| MCRB | SERES THERAPEUTICS INC | 10 | 10 | 0.36% | 0.76% | 1.12% | Q4 2020 | Q1 2023 | 10 |
| CLDX | CELLDEX THERAPEUTICS I... | 9 | 1 | 0.10% | 0.70% | 1.30% | Q4 2020 | Q2 2023 | 10 |
| HZNP | HORIZON THERAPEUTICS P... | 9 | 9 | 0.21% | 1.94% | 3.25% | Q4 2020 | Q4 2022 | 9 |
| AMYT | AMRYT PHARMA PLC | 9 | 9 | 0.38% | 1.76% | 3.52% | Q4 2020 | Q4 2022 | 9 |
| AKRO | AKERO THERAPEUTICS INC | 6 | 3 | 0.36% | 1.72% | 3.49% | Q4 2020 | Q3 2023 | 9 |
| XENE | XENON PHARMACEUTICALS INC | 9 | 9 | 0.17% | 1.47% | 3.00% | Q3 2021 | Q3 2023 | 9 |
| VRAY | VIEWRAY INC | 9 | 9 | 0.01% | 1.47% | 3.99% | Q2 2021 | Q2 2023 | 9 |
| MRSN | MERSANA THERAPEUTICS INC | 6 | 3 | 0.17% | 1.16% | 2.27% | Q4 2020 | Q3 2023 | 9 |
| SGEN | SEAGEN INC | 9 | 9 | 0.38% | 0.79% | 2.22% | Q4 2020 | Q4 2022 | 9 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 5 | 4 | 0.02% | 0.49% | 0.99% | Q1 2021 | Q3 2023 | 9 |
| BLU | BELLUS HEALTH INC NEW | 8 | 8 | 0.07% | 2.82% | 5.91% | Q2 2021 | Q1 2023 | 8 |
| PSTX | POSEIDA THERAPEUTICS INC | 8 | 8 | 0.30% | 1.93% | 3.42% | Q4 2021 | Q3 2023 | 8 |
| KRYS | KRYSTAL BIOTECH INC | 8 | 8 | 1.12% | 1.92% | 4.32% | Q4 2021 | Q3 2023 | 8 |
| BCRX | BIOCRYST PHARMACEUTICA... | 7 | 1 | 0.08% | 0.97% | 1.99% | Q4 2020 | Q3 2023 | 8 |
| PNT | POINT BIOPHARMA GLOBAL... | 5 | 3 | 0.19% | 0.51% | 0.84% | Q3 2021 | Q3 2023 | 8 |
| SNDX | SYNDAX PHARMACEUTICALS... | 3 | 2 | 0.09% | 0.42% | 0.89% | Q4 2020 | Q3 2023 | 8 |
| BHVN | BIOHAVEN PHARMACTL HLD... | 7 | 7 | 0.82% | 2.50% | 4.86% | Q4 2020 | Q2 2022 | 7 |
| CRNX | Crinetics Pharmaceutic... | 6 | 1 | 0.59% | 1.07% | 1.98% | Q3 2021 | Q3 2023 | 7 |
| ETNB | 89BIO INC | 3 | 1 | 0.23% | 1.05% | 2.76% | Q4 2020 | Q3 2023 | 7 |
| OTIC | OTONOMY INC | 7 | 7 | 0.35% | 0.90% | 1.20% | Q4 2020 | Q2 2022 | 7 |
| EYPT | EYEPOINT PHARMACEUTICA... | 7 | 7 | 0.29% | 0.86% | 1.66% | Q1 2021 | Q3 2022 | 7 |
| STXS | STEREOTAXIS INC | 7 | 7 | 0.21% | 0.60% | 1.32% | Q2 2021 | Q4 2022 | 7 |
| ELIEM THERAPEUTICS INC | 7 | 7 | 0.10% | 0.42% | 0.66% | Q1 2022 | Q3 2023 | 7 | |
| MREO | MEREO BIOPHARMA GROUP PLC | 7 | 7 | 0.05% | 0.33% | 0.58% | Q4 2020 | Q2 2022 | 7 |
| MSACW | Medicus Sciences Acqui... | 7 | 7 | 0.00% | 0.01% | 0.02% | Q2 2021 | Q4 2022 | 7 |
| ORIC | ORIC PHARMACEUTICALS INC | 6 | 6 | 1.31% | 2.30% | 3.48% | Q2 2022 | Q3 2023 | 6 |
| SRRA | SIERRA ONCOLOGY INC | 6 | 6 | 1.21% | 2.22% | 5.88% | Q4 2020 | Q1 2022 | 6 |
| MGNX | MACROGENICS INC | 5 | 1 | 0.12% | 1.87% | 4.03% | Q2 2021 | Q3 2023 | 6 |
| JNCE | JOUNCE THERAPEUTICS INC | 6 | 6 | 0.70% | 1.13% | 1.96% | Q4 2020 | Q1 2022 | 6 |
| ASND | ASCENDIS PHARMA A/S | 3 | 1 | 0.18% | 0.82% | 1.70% | Q4 2020 | Q4 2022 | 6 |
| ELOX | ELOXX PHARMACEUTICALS INC | 6 | 6 | 0.06% | 0.66% | 1.68% | Q2 2021 | Q3 2022 | 6 |
| PYPD | POLYPID LTD | 6 | 6 | 0.23% | 0.57% | 0.81% | Q1 2021 | Q2 2022 | 6 |
| NTLA | INTELLIA THERAPEUTICS INC | 5 | 1 | 0.33% | 0.51% | 0.64% | Q3 2021 | Q3 2023 | 6 |
| CALA | CALITHERA BIOSCIENCES INC | 6 | 6 | 0.03% | 0.07% | 0.23% | Q4 2020 | Q1 2022 | 6 |
| XBI | SPRD S&P Biotech ETF | 3 | 1 | 4.76% | 7.47% | 11.16% | Q2 2021 | Q3 2023 | 5 |
| CTIC | CTI BIOPHARMA CORP | 5 | 5 | 0.44% | 2.15% | 4.35% | Q4 2021 | Q4 2022 | 5 |
| HALO | HALOZYME THERAPEUTICS INC | 5 | 5 | 1.16% | 1.75% | 2.48% | Q4 2020 | Q4 2021 | 5 |
| TERN | TERNS PHARMACEUTICALS INC | 5 | 5 | 0.03% | 1.54% | 3.26% | Q3 2022 | Q3 2023 | 5 |
| KALV | KALVISTA PHARMACEUTICA... | 3 | 2 | 0.16% | 1.18% | 2.35% | Q1 2021 | Q3 2023 | 5 |
| PLRX | PLIANT THERAPEUTICS INC | 5 | 5 | 0.60% | 1.14% | 1.48% | Q3 2022 | Q3 2023 | 5 |
| HLXA | HELIX ACQUISITION CORP | 5 | 5 | 0.53% | 1.11% | 1.42% | Q4 2020 | Q4 2021 | 5 |
| NXTC | NEXTCURE INC | 4 | 1 | 0.39% | 1.09% | 2.75% | Q4 2020 | Q1 2022 | 5 |
| KURA | KURA ONCOLOGY INC | 5 | 5 | 0.38% | 0.94% | 1.71% | Q4 2020 | Q4 2021 | 5 |
| CGEM | CULLINAN ONCOLOGY INC | 4 | 1 | 0.69% | 0.90% | 1.12% | Q2 2021 | Q1 2023 | 5 |
| DCPH | DECIPHERA PHARMACEUTIC... | 5 | 5 | 0.61% | 0.84% | 1.28% | Q4 2020 | Q4 2021 | 5 |
| LPTX | LEAP THERAPEUTICS INC | 3 | 2 | 0.31% | 0.83% | 1.40% | Q4 2020 | Q1 2022 | 5 |
| CYCC | CYCLACEL PHARMACEUTICA... | 5 | 5 | 0.58% | 0.82% | 1.16% | Q1 2021 | Q1 2022 | 5 |
| TRVI | TREVI THERAPEUTICS INC | 5 | 5 | 0.42% | 0.57% | 0.68% | Q3 2022 | Q3 2023 | 5 |
| ISEE | IVERIC BIO INC | 2 | 1 | 0.28% | 0.57% | 1.08% | Q4 2020 | Q4 2022 | 5 |
| ALGS | ALIGOS THERAPEUTICS INC | 3 | 2 | 0.01% | 0.12% | 0.23% | Q1 2022 | Q3 2023 | 5 |
| RENOVACOR INC | 5 | 5 | 0.00% | 0.01% | 0.02% | Q3 2021 | Q3 2022 | 5 | |
| DRNA | DICERNA PHARMACEUTICAL... | 4 | 4 | 0.35% | 2.47% | 3.83% | Q4 2020 | Q3 2021 | 4 |
| RACB | RESEARCH ALLIANCE CORP II | 4 | 4 | 2.20% | 2.47% | 2.80% | Q1 2021 | Q4 2021 | 4 |
| APEN | APOLLO ENDOSURGERY INC | 4 | 4 | 1.21% | 2.09% | 2.53% | Q4 2021 | Q3 2022 | 4 |
| CRIS | CURIS INC | 4 | 4 | 0.28% | 1.90% | 3.88% | Q4 2020 | Q3 2021 | 4 |
| SDGR | Schrodinger Inc | 4 | 4 | 0.26% | 1.89% | 4.42% | Q4 2022 | Q3 2023 | 4 |
| NUVALENT INC | 4 | 4 | 0.27% | 1.85% | 3.03% | Q3 2022 | Q2 2023 | 4 | |
| ITOS | ITEOS THERAPEUTICS INC | 4 | 4 | 0.86% | 1.78% | 2.60% | Q2 2021 | Q1 2022 | 4 |
| MRTX | MIRATI THERAPEUTICS INC | 2 | 2 | 1.00% | 1.69% | 2.08% | Q2 2022 | Q3 2023 | 4 |
| IMVT | IMMUNOVANT INC | 2 | 2 | 0.44% | 1.58% | 2.68% | Q4 2020 | Q4 2022 | 4 |
| GILD | Gilead Sciences Inc | 4 | 4 | 1.28% | 1.55% | 2.06% | Q4 2022 | Q3 2023 | 4 |
| ARVN | ARVINAS INC | 2 | 1 | 0.61% | 1.49% | 2.71% | Q4 2020 | Q3 2022 | 4 |
| RNLX | RENALYTIX PLC | 4 | 4 | 0.42% | 1.34% | 1.88% | Q4 2020 | Q3 2021 | 4 |
| PRTA | PROTHENA CORP PLC | 2 | 2 | 0.39% | 1.23% | 2.26% | Q3 2022 | Q3 2023 | 4 |
| ADMS | ADAMAS PHARMACEUTICALS... | 4 | 4 | 0.80% | 1.14% | 1.37% | Q4 2020 | Q3 2021 | 4 |
| AFMD | AFFIMED N V | 4 | 4 | 0.16% | 1.11% | 2.17% | Q4 2020 | Q3 2021 | 4 |
| IMGN | IMMUNOGEN INC | 2 | 1 | 0.33% | 0.98% | 1.79% | Q1 2022 | Q3 2023 | 4 |
| PRAX | Praxis Precision Medic... | 2 | 2 | 0.07% | 0.88% | 2.14% | Q3 2022 | Q3 2023 | 4 |
| CVRX | CVRX INC | 4 | 4 | 0.12% | 0.82% | 1.65% | Q2 2022 | Q1 2023 | 4 |
| MSAC | MEDICUS SCIENCES ACQUI... | 4 | 4 | 0.50% | 0.81% | 1.61% | Q2 2021 | Q1 2022 | 4 |
| ARNA | ARENA PHARMACEUTICALS INC | 4 | 4 | 0.62% | 0.73% | 0.89% | Q4 2020 | Q3 2021 | 4 |
| GH | GUARDANT HEALTH INC | 4 | 4 | 0.26% | 0.70% | 1.41% | Q4 2020 | Q3 2021 | 4 |
| ALLK | ALLAKOS INC | 4 | 4 | 0.27% | 0.66% | 1.16% | Q3 2022 | Q2 2023 | 4 |
| BNTC | BENITEC BIOPHARMA INC | 4 | 4 | 0.02% | 0.63% | 1.00% | Q2 2021 | Q1 2022 | 4 |
| SURF | SURFACE ONCOLOGY INC | 4 | 4 | 0.21% | 0.41% | 0.70% | Q4 2020 | Q3 2021 | 4 |
| CDXS | CODEXIS INC | 4 | 4 | 0.19% | 0.41% | 0.69% | Q1 2022 | Q4 2022 | 4 |
| Eloxx Pharmaceuticals Inc | 4 | 4 | 0.01% | 0.05% | 0.08% | Q4 2022 | Q3 2023 | 4 | |
| ATHA | ATHIRA PHARMA INC | 2 | 1 | 0.54% | 4.09% | 11.16% | Q2 2021 | Q1 2022 | 3 |
| RXDX | PROMETHEUS BIOSCIENCES... | 3 | 3 | 2.62% | 4.04% | 5.42% | Q2 2022 | Q4 2022 | 3 |
| AKRO | Akero Therapeutics Inc | 2 | 1 | 2.35% | 2.94% | 3.42% | Q4 2022 | Q3 2023 | 3 |
| AVXL | ANAVEX LIFE SCIENCES CORP | 3 | 3 | 2.67% | 2.93% | 3.29% | Q2 2022 | Q4 2022 | 3 |
| ALNY | ALNYLAM PHARMACEUTICAL... | 3 | 3 | 1.16% | 1.97% | 2.56% | Q3 2022 | Q1 2023 | 3 |
| TCRR | TCR2 THERAPEUTICS INC | 3 | 3 | 1.38% | 1.90% | 2.44% | Q4 2020 | Q2 2021 | 3 |
| MDGL | MADRIGAL PHARMACEUTICA... | 2 | 1 | 0.11% | 1.75% | 4.14% | Q2 2021 | Q1 2023 | 3 |
| VERU | VERU INC | 3 | 3 | 0.26% | 1.71% | 2.72% | Q2 2022 | Q4 2022 | 3 |
| VSTM | VERASTEM INC | 3 | 3 | 1.40% | 1.64% | 1.90% | Q4 2020 | Q2 2021 | 3 |
| ACRS | Aclaris Therapeutics, Inc | 3 | 3 | 0.41% | 1.56% | 2.18% | Q1 2023 | Q3 2023 | 3 |
| ISEE | IVERIC BIO INC | 3 | 3 | 0.66% | 1.54% | 2.69% | Q1 2022 | Q3 2022 | 3 |
| DCTH | DELCATH SYS INC | 3 | 3 | 0.27% | 1.50% | 3.66% | Q4 2020 | Q2 2021 | 3 |
| APLS | APELLIS PHARMACEUTICAL... | 2 | 1 | 0.20% | 1.41% | 2.22% | Q2 2021 | Q2 2022 | 3 |
| FULC | FULCRUM THERAPEUTICS INC | 2 | 1 | 0.11% | 1.28% | 2.96% | Q4 2020 | Q3 2021 | 3 |
| CCXI | CHEMOCENTRYX INC | 2 | 1 | 0.20% | 1.23% | 1.93% | Q4 2020 | Q2 2022 | 3 |
| LHDX | LUCIRA HEALTH INC | 3 | 3 | 0.46% | 1.07% | 1.80% | Q3 2021 | Q1 2022 | 3 |
| PHVS | Pharvaris NV | 3 | 3 | 0.32% | 1.04% | 1.86% | Q4 2022 | Q2 2023 | 3 |
| KPTI | Karyopharm Therapeutic... | 3 | 3 | 0.23% | 1.00% | 2.48% | Q1 2023 | Q3 2023 | 3 |
| MIRM | Mirum Pharmaceuticals Inc | 3 | 3 | 0.85% | 0.99% | 1.06% | Q1 2023 | Q3 2023 | 3 |
| TELA | Tela Bio Inc | 3 | 3 | 0.24% | 0.91% | 1.30% | Q1 2023 | Q3 2023 | 3 |
| NKTX | NKARTA INC | 2 | 1 | 0.42% | 0.86% | 1.61% | Q4 2020 | Q3 2022 | 3 |
| RXDX | PROMETHEUS BIOSCIENCES... | 2 | 1 | 0.15% | 0.78% | 1.57% | Q1 2021 | Q1 2023 | 3 |
| CYTK | CYTOKINETICS INC | 2 | 1 | 0.23% | 0.77% | 1.08% | Q3 2021 | Q4 2022 | 3 |
| VTGN | VISTAGEN THERAPEUTICS INC | 3 | 3 | 0.34% | 0.77% | 1.10% | Q2 2021 | Q4 2021 | 3 |
| DNAA | SOCIAL CAP SUVRETTA HL... | 3 | 3 | 0.50% | 0.74% | 1.13% | Q2 2021 | Q4 2021 | 3 |
| DNAB | SOCIAL CAP SUVRETTA HL... | 3 | 3 | 0.50% | 0.74% | 1.13% | Q2 2021 | Q4 2021 | 3 |
| DNAC | SOCIAL CAP SUVRETTA HL... | 3 | 3 | 0.50% | 0.74% | 1.13% | Q2 2021 | Q4 2021 | 3 |
| DNAD | SOCIAL CAP SUVRETTA HL... | 3 | 3 | 0.49% | 0.74% | 1.13% | Q2 2021 | Q4 2021 | 3 |
| ABOS | ACUMEN PHARMACEUTICALS... | 3 | 3 | 0.25% | 0.71% | 1.42% | Q3 2022 | Q1 2023 | 3 |
| PHR | PHREESIA INC | 3 | 3 | 0.60% | 0.70% | 0.79% | Q2 2022 | Q4 2022 | 3 |
| NGM | NGM BIOPHARMACEUTICALS... | 3 | 3 | 0.35% | 0.68% | 1.26% | Q1 2022 | Q3 2022 | 3 |
| ZNTL | ZENTALIS PHARMACEUTICA... | 2 | 1 | 0.30% | 0.68% | 0.90% | Q4 2020 | Q3 2021 | 3 |
| SRPT | Sarepta Therapeutics Inc | 3 | 3 | 0.34% | 0.64% | 1.06% | Q1 2023 | Q3 2023 | 3 |
| SRRK | Scholar Rock Holding Corp | 2 | 1 | 0.02% | 0.58% | 1.00% | Q4 2020 | Q3 2023 | 3 |
| TRILLIUM THERAPEUTICS INC | 3 | 3 | 0.35% | 0.57% | 0.94% | Q4 2020 | Q2 2021 | 3 | |
| LVTX | LAVA THERAPEUTICS NV | 3 | 3 | 0.10% | 0.49% | 0.94% | Q3 2022 | Q1 2023 | 3 |
| PTGX | PROTAGONIST THERAPEUTI... | 2 | 1 | 0.21% | 0.49% | 1.00% | Q4 2020 | Q2 2023 | 3 |
| BBIO | BRIDGEBIO PHARMA INC | 2 | 1 | 0.27% | 0.41% | 0.68% | Q4 2021 | Q2 2023 | 3 |
| CUE | Cue Biopharma Inc | 3 | 3 | 0.25% | 0.39% | 0.46% | Q4 2022 | Q2 2023 | 3 |
| FMTX | FORMA THERAPEUTICS HLD... | 2 | 1 | 0.11% | 0.33% | 0.67% | Q2 2021 | Q2 2022 | 3 |
| ARDX | ARDELYX INC | 3 | 3 | 0.16% | 0.32% | 0.45% | Q4 2020 | Q2 2021 | 3 |
| RCKT | ROCKET PHARMACEUTICALS... | 3 | 3 | 0.20% | 0.25% | 0.32% | Q4 2020 | Q2 2021 | 3 |
| MDNA | MEDICENNA THERAPEUTICS... | 3 | 3 | 0.15% | 0.23% | 0.29% | Q4 2020 | Q2 2021 | 3 |
| WVE | WAVE LIFE SCIENCES LTD | 2 | 1 | 0.10% | 0.20% | 0.37% | Q1 2021 | Q4 2022 | 3 |
| MGTX | Meiragtx Holdings Plc | 3 | 3 | 0.11% | 0.13% | 0.16% | Q2 2022 | Q4 2022 | 3 |
| PHGE | BIOMX INC | 3 | 3 | 0.04% | 0.05% | 0.05% | Q4 2020 | Q2 2021 | 3 |
| CHAQWS | CHARDAN HEALTHCR ACQST... | 3 | 3 | 0.03% | 0.04% | 0.05% | Q4 2020 | Q2 2021 | 3 |
| Rocket Pharmaceuticals... | 3 | 3 | 0.01% | 0.01% | 0.01% | Q1 2023 | Q3 2023 | 3 | |
| Fresh Tracks Therapeut... | 3 | 3 | 0.00% | 0.00% | 0.00% | Q4 2022 | Q2 2023 | 3 | |
| VCEL | VERICEL CORP | 2 | 2 | 3.70% | 4.37% | 5.05% | Q4 2020 | Q1 2021 | 2 |
| LRMR | LARIMAR THERAPEUTICS INC | 2 | 2 | 1.53% | 2.12% | 2.70% | Q4 2020 | Q1 2021 | 2 |
| MoonLake Immunotherape... | 2 | 2 | 0.93% | 2.04% | 3.16% | Q1 2023 | Q2 2023 | 2 | |
| AKRO | Akero Therapeutics Inc | 1 | 1 | 1.64% | 1.99% | 2.35% | Q4 2022 | Q3 2023 | 2 |
| GLPG | GALAPAGOS NV | 2 | 2 | 1.05% | 1.97% | 2.88% | Q4 2021 | Q1 2022 | 2 |
| VKTX | Viking Therapeutics Inc | 2 | 2 | 1.30% | 1.95% | 2.61% | Q1 2023 | Q2 2023 | 2 |
| EPIX | ESSA PHARMA INC | 2 | 2 | 1.16% | 1.70% | 2.24% | Q4 2020 | Q1 2021 | 2 |
| CBAY | CymaBay Therapeutics Inc | 2 | 2 | 0.54% | 1.60% | 2.67% | Q2 2023 | Q3 2023 | 2 |
| ALDX | ALDEYRA THERAPEUTICS INC | 2 | 2 | 0.97% | 1.53% | 2.09% | Q1 2021 | Q2 2021 | 2 |
| CLRB | CELLECTAR BIOSCIENCES INC | 2 | 2 | 0.53% | 1.34% | 2.14% | Q4 2020 | Q1 2021 | 2 |
| OLMA | Olema Pharmaceuticals Inc | 2 | 2 | 1.09% | 1.31% | 1.53% | Q2 2023 | Q3 2023 | 2 |
| RYTM | Rhythm Pharmaceuticals... | 2 | 2 | 0.59% | 1.20% | 1.81% | Q2 2023 | Q3 2023 | 2 |
| TPTX | TURNING POINT THERAPEU... | 2 | 2 | 0.86% | 1.00% | 1.14% | Q4 2020 | Q1 2021 | 2 |
| CCXI | CHEMOCENTRYX INC | 2 | 2 | 0.60% | 0.97% | 1.35% | Q2 2021 | Q3 2021 | 2 |
| SLRX | SALARIUS PHARMACEUTICA... | 2 | 2 | 0.22% | 0.92% | 1.61% | Q1 2021 | Q2 2021 | 2 |
| BCAB | BIOATLA INC | 2 | 2 | 0.52% | 0.91% | 1.29% | Q3 2022 | Q4 2022 | 2 |
| RGNX | REGENXBIO INC | 2 | 2 | 0.79% | 0.89% | 0.98% | Q2 2022 | Q3 2022 | 2 |
| INCY | Incyte Corp | 2 | 2 | 0.66% | 0.83% | 1.01% | Q1 2023 | Q2 2023 | 2 |
| GOSS | Gossamer Bio Inc | 1 | 1 | 0.06% | 0.80% | 1.55% | Q4 2022 | Q3 2023 | 2 |
| ALT | Altimmune, Inc. | 2 | 2 | 0.72% | 0.74% | 0.75% | Q4 2022 | Q1 2023 | 2 |
| PHAT | Phathom Pharmaceutical... | 2 | 2 | 0.59% | 0.74% | 0.89% | Q1 2023 | Q2 2023 | 2 |
| MRSN | Mersana Therapeutics Inc | 2 | 2 | 0.31% | 0.71% | 1.12% | Q2 2023 | Q3 2023 | 2 |
| ASLN | ASLAN PHARMACEUTICALS LTD | 2 | 2 | 0.66% | 0.67% | 0.68% | Q4 2021 | Q1 2022 | 2 |
| ODT | ODONATE THERAPEUTICS INC | 2 | 2 | 0.29% | 0.61% | 0.93% | Q1 2021 | Q2 2021 | 2 |
| Ventyx Biosciences Inc | 2 | 2 | 0.25% | 0.61% | 0.97% | Q1 2023 | Q2 2023 | 2 | |
| Zura Bio Ltd | 2 | 2 | 0.41% | 0.61% | 0.81% | Q2 2023 | Q3 2023 | 2 | |
| ZYME | ZYMEWORKS INC | 1 | 1 | 0.34% | 0.59% | 0.85% | Q4 2020 | Q2 2022 | 2 |
| SAGE | SAGE THERAPEUTICS INC | 2 | 2 | 0.24% | 0.53% | 0.82% | Q1 2021 | Q2 2021 | 2 |
| RETA | REATA PHARMACEUTICALS INC | 1 | 1 | 0.39% | 0.49% | 0.59% | Q2 2021 | Q2 2023 | 2 |
| CGEN | COMPUGEN LTD | 2 | 2 | 0.10% | 0.47% | 0.84% | Q3 2021 | Q4 2021 | 2 |
| RAPT | RAPT THERAPEUTICS INC | 2 | 2 | 0.21% | 0.44% | 0.67% | Q2 2021 | Q3 2021 | 2 |
| Astria Therapeutics Inc | 2 | 2 | 0.35% | 0.43% | 0.52% | Q4 2022 | Q1 2023 | 2 | |
| KALA | KALA PHARMACEUTICALS INC | 2 | 2 | 0.38% | 0.39% | 0.40% | Q4 2020 | Q1 2021 | 2 |
| RLMD | RELMADA THERAPEUTICS INC | 1 | 1 | 0.09% | 0.38% | 0.67% | Q2 2021 | Q3 2023 | 2 |
| ALKS | Alkermes Plc | 2 | 2 | 0.35% | 0.37% | 0.39% | Q2 2023 | Q3 2023 | 2 |
| AVTE | Aerovate Therapeutics Inc | 1 | 1 | 0.31% | 0.36% | 0.41% | Q4 2022 | Q3 2023 | 2 |
| ANNX | Annexon Inc | 2 | 2 | 0.29% | 0.36% | 0.42% | Q2 2023 | Q3 2023 | 2 |
| ALT | ALTIMMUNE INC | 2 | 2 | 0.24% | 0.34% | 0.43% | Q3 2022 | Q4 2022 | 2 |
| AVXL | ANAVEX LIFE SCIENCES CORP | 2 | 2 | 0.27% | 0.31% | 0.35% | Q3 2022 | Q4 2022 | 2 |
| ATNM | ACTINIUM PHARMACEUTICA... | 2 | 2 | 0.19% | 0.30% | 0.41% | Q4 2020 | Q1 2021 | 2 |
| VYGR | Voyager Therapeutics Inc | 2 | 2 | 0.24% | 0.30% | 0.35% | Q2 2023 | Q3 2023 | 2 |
| CMPX | COMPASS THERAPEUTICS INC | 2 | 2 | 0.20% | 0.29% | 0.39% | Q3 2022 | Q4 2022 | 2 |
| Jasper Therapeutics Inc | 2 | 2 | 0.21% | 0.29% | 0.37% | Q1 2023 | Q2 2023 | 2 | |
| RACA | THERAPEUTICS ACQUISITI... | 2 | 2 | 0.23% | 0.27% | 0.32% | Q4 2020 | Q1 2021 | 2 |
| BMRN | BioMarin Pharmaceutica... | 2 | 2 | 0.27% | 0.27% | 0.27% | Q2 2023 | Q3 2023 | 2 |
| RZLT | Rezolute Inc | 2 | 2 | 0.17% | 0.24% | 0.31% | Q2 2023 | Q3 2023 | 2 |
| IMUX | IMMUNIC INC | 1 | 1 | 0.14% | 0.23% | 0.32% | Q1 2022 | Q4 2022 | 2 |
| SLNO | SOLENO THERAPEUTICS INC | 2 | 2 | 0.09% | 0.22% | 0.36% | Q4 2020 | Q1 2021 | 2 |
| GMDA | GAMIDA CELL LTD | 2 | 2 | 0.10% | 0.22% | 0.34% | Q4 2020 | Q1 2021 | 2 |
| AYLA | AYALA PHARMACEUTICALS INC | 2 | 2 | 0.11% | 0.18% | 0.26% | Q2 2021 | Q3 2021 | 2 |
| Biohaven Ltd | 2 | 2 | 0.08% | 0.11% | 0.15% | Q2 2023 | Q3 2023 | 2 | |
| QURE | UNIQURE NV | 1 | 1 | 0.06% | 0.10% | 0.13% | Q2 2021 | Q4 2022 | 2 |
| GLUE | Monte Rosa Therapeutic... | 2 | 2 | 0.07% | 0.08% | 0.10% | Q1 2023 | Q2 2023 | 2 |
| CLNN | Clene Inc | 2 | 2 | 0.07% | 0.07% | 0.08% | Q2 2023 | Q3 2023 | 2 |
| PIRS | PIERIS PHARMACEUTICALS... | 1 | 1 | 0.05% | 0.06% | 0.07% | Q1 2021 | Q2 2023 | 2 |
| QQQ | INVESCO QQQ TR | 1 | 1 | 14.02% | 14.02% | 14.02% | Q2 2022 | Q2 2022 | 1 |
| KDNY | CHINOOK THERAPEUTICS INC | 1 | 1 | 5.70% | 5.70% | 5.70% | Q2 2021 | Q2 2021 | 1 |
| RLMD | RELMADA THERAPEUTICS INC | 1 | 1 | 4.92% | 4.92% | 4.92% | Q3 2022 | Q3 2022 | 1 |
| BIOGEN INC | 1 | 1 | 4.27% | 4.27% | 4.27% | Q4 2020 | Q4 2020 | 1 | |
| Soleno Therapeutics Inc | 1 | 1 | 3.31% | 3.31% | 3.31% | Q3 2023 | Q3 2023 | 1 | |
| MDGL | Madrigal Parmaceutical... | 1 | 1 | 2.49% | 2.49% | 2.49% | Q4 2022 | Q4 2022 | 1 |
| STRO | SUTRO BIOPHARMA INC | 1 | 1 | 2.33% | 2.33% | 2.33% | Q4 2020 | Q4 2020 | 1 |
| PLRX | Pliant Therapeutics, Inc | 1 | 1 | 2.19% | 2.19% | 2.19% | Q1 2023 | Q1 2023 | 1 |
| MSACU | MEDICUS SCIENCES ACQUI... | 1 | 1 | 2.19% | 2.19% | 2.19% | Q1 2021 | Q1 2021 | 1 |
| URGN | Urogen Pharma Ltd | 1 | 1 | 2.16% | 2.16% | 2.16% | Q3 2023 | Q3 2023 | 1 |
| ALNY | ALNYLAM PHARMACEUTICAL... | 1 | 1 | 1.80% | 1.80% | 1.80% | Q2 2022 | Q2 2022 | 1 |
| REGN | Regeneron Pharmaceutic... | 1 | 1 | 1.70% | 1.70% | 1.70% | Q1 2023 | Q1 2023 | 1 |
| NVO | Novo Nordisk A/S | 1 | 1 | 1.65% | 1.65% | 1.65% | Q3 2023 | Q3 2023 | 1 |
| CLNN | CLENE INC | 1 | 1 | 1.64% | 1.64% | 1.64% | Q3 2022 | Q3 2022 | 1 |
| KALV | KalVista Pharmaceutica... | 1 | 1 | 1.55% | 1.55% | 1.55% | Q3 2023 | Q3 2023 | 1 |
| BIIB | BIOGEN INC | 1 | 1 | 1.53% | 1.53% | 1.53% | Q1 2021 | Q1 2021 | 1 |
| CFRX | CONTRAFECT CORP | 1 | 1 | 1.48% | 1.48% | 1.48% | Q2 2022 | Q2 2022 | 1 |
| HUM | Humana Inc | 1 | 1 | 1.48% | 1.48% | 1.48% | Q3 2023 | Q3 2023 | 1 |
| Cincor Pharma Inc | 1 | 1 | 1.39% | 1.39% | 1.39% | Q4 2022 | Q4 2022 | 1 | |
| GlaxoSmithKline PLC | 1 | 1 | 1.37% | 1.37% | 1.37% | Q4 2022 | Q4 2022 | 1 | |
| MCRB | SERES THERAPEUTICS INC | 1 | 1 | 1.30% | 1.30% | 1.30% | Q2 2021 | Q2 2021 | 1 |
| Caribou Biosciences Inc | 1 | 1 | 1.29% | 1.29% | 1.29% | Q3 2023 | Q3 2023 | 1 | |
| ETNB | 89bio, Inc | 1 | 1 | 1.26% | 1.26% | 1.26% | Q1 2023 | Q1 2023 | 1 |
| PCVX | Vaxcyte Inc | 1 | 1 | 1.14% | 1.14% | 1.14% | Q4 2022 | Q4 2022 | 1 |
| ERASCA INC | 1 | 1 | 1.12% | 1.12% | 1.12% | Q3 2021 | Q3 2021 | 1 | |
| ONCR | ONCORUS INC | 1 | 1 | 0.99% | 0.99% | 0.99% | Q1 2021 | Q1 2021 | 1 |
| AUPH | AURINIA PHARMACEUTICAL... | 1 | 1 | 0.93% | 0.93% | 0.93% | Q4 2021 | Q4 2021 | 1 |
| CBAY | CymaBay Therapeutics Inc | 1 | 1 | 0.90% | 0.90% | 0.90% | Q3 2023 | Q3 2023 | 1 |
| ANIP | ANI Pharmaceuticals Inc | 1 | 1 | 0.90% | 0.90% | 0.90% | Q2 2023 | Q2 2023 | 1 |
| RVPH | Reviva Pharmaceuticals... | 1 | 1 | 0.84% | 0.84% | 0.84% | Q3 2023 | Q3 2023 | 1 |
| RNA | Avidity Biosciences Inc | 1 | 1 | 0.81% | 0.81% | 0.81% | Q4 2022 | Q4 2022 | 1 |
| CHRS | COHERUS BIOSCIENCES INC | 1 | 1 | 0.80% | 0.80% | 0.80% | Q1 2021 | Q1 2021 | 1 |
| NBIX | NEUROCRINE BIOSCIENCES... | 1 | 1 | 0.80% | 0.80% | 0.80% | Q1 2022 | Q1 2022 | 1 |
| KRTX | KARUNA THERAPEUTICS INC | 1 | 1 | 0.78% | 0.78% | 0.78% | Q3 2022 | Q3 2022 | 1 |
| RCUS | ARCUS BIOSCIENCES INC | 1 | 1 | 0.74% | 0.74% | 0.74% | Q2 2021 | Q2 2021 | 1 |
| CERE | CEREVEL THERAPEUTICS H... | 1 | 1 | 0.74% | 0.74% | 0.74% | Q2 2021 | Q2 2021 | 1 |
| ESPR | ESPERION THERAPEUTICS ... | 1 | 1 | 0.71% | 0.71% | 0.71% | Q3 2022 | Q3 2022 | 1 |
| Molecular Templates Inc | 1 | 1 | 0.68% | 0.68% | 0.68% | Q3 2023 | Q3 2023 | 1 | |
| KOD | Kodiak Sciences Inc | 1 | 1 | 0.61% | 0.61% | 0.61% | Q3 2023 | Q3 2023 | 1 |
| KDMN | KADMON HLDGS INC | 1 | 1 | 0.58% | 0.58% | 0.58% | Q4 2020 | Q4 2020 | 1 |
| DAWN | DAY ONE BIOPHARMACEUTI... | 1 | 1 | 0.58% | 0.58% | 0.58% | Q2 2022 | Q2 2022 | 1 |
| AMAM | Ambrx Biopharma Inc | 1 | 1 | 0.51% | 0.51% | 0.51% | Q2 2023 | Q2 2023 | 1 |
| ALXN | ALEXION PHARMACEUTICAL... | 1 | 1 | 0.45% | 0.45% | 0.45% | Q4 2020 | Q4 2020 | 1 |
| INBX | INHIBRX INC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q4 2021 | Q4 2021 | 1 |
| CALITHERA BIOSCIENCES INC | 1 | 1 | 0.43% | 0.43% | 0.43% | Q4 2020 | Q4 2020 | 1 | |
| HGEN | HUMANIGEN INC | 1 | 1 | 0.43% | 0.43% | 0.43% | Q2 2022 | Q2 2022 | 1 |
| CNST | CONSTELLATION PHARMCET... | 1 | 1 | 0.42% | 0.42% | 0.42% | Q4 2020 | Q4 2020 | 1 |
| CRIS | CURIS INC | 1 | 1 | 0.39% | 0.39% | 0.39% | Q4 2021 | Q4 2021 | 1 |
| EXAS | EXACT SCIENCES CORP | 1 | 1 | 0.38% | 0.38% | 0.38% | Q4 2020 | Q4 2020 | 1 |
| Roivant Sciences Ltd | 1 | 1 | 0.35% | 0.35% | 0.35% | Q3 2023 | Q3 2023 | 1 | |
| IPHA | INNATE PHARMA S A | 1 | 1 | 0.34% | 0.34% | 0.34% | Q4 2021 | Q4 2021 | 1 |
| APTOSE BIOSCIENCES INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q1 2021 | Q1 2021 | 1 | |
| VYNE | VYNE THERAPEUTICS INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q4 2020 | Q4 2020 | 1 |
| CLXPF | CYBIN INC | 1 | 1 | 0.31% | 0.31% | 0.31% | Q3 2021 | Q3 2021 | 1 |
| WVE | WAVE LIFE SCIENCES LTD | 1 | 1 | 0.31% | 0.31% | 0.31% | Q1 2021 | Q1 2021 | 1 |
| BLRX | BIOLINERX LTD | 1 | 1 | 0.30% | 0.30% | 0.30% | Q1 2021 | Q1 2021 | 1 |
| CLDX | CELLDEX THERAPEUTICS I... | 1 | 1 | 0.30% | 0.30% | 0.30% | Q2 2022 | Q2 2022 | 1 |
| CABA | CABALETTA BIO INC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q3 2021 | Q3 2021 | 1 |
| SBTX | SILVERBACK THERAPEUTIC... | 1 | 1 | 0.27% | 0.27% | 0.27% | Q2 2022 | Q2 2022 | 1 |
| TVTX | TRAVERE THERAPEUTICS INC | 1 | 1 | 0.27% | 0.27% | 0.27% | Q1 2021 | Q1 2021 | 1 |
| IOVA | IOVANCE BIOTHERAPEUTIC... | 1 | 1 | 0.27% | 0.27% | 0.27% | Q4 2020 | Q4 2020 | 1 |
| Sagimet Biosciences Inc | 1 | 1 | 0.27% | 0.27% | 0.27% | Q3 2023 | Q3 2023 | 1 | |
| EVLO | EVELO BIOSCIENCES INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q3 2021 | Q3 2021 | 1 |
| KROS | KEROS THERAPEUTICS INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2021 | Q3 2021 | 1 |
| AXSM | Axsome Therapeutics Inc | 1 | 1 | 0.22% | 0.22% | 0.22% | Q4 2022 | Q4 2022 | 1 |
| APTX | APTINYX INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q4 2020 | Q4 2020 | 1 |
| APTX | APTINYX INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q1 2022 | Q1 2022 | 1 |
| CATABASIS PHARMACEUTIC... | 1 | 1 | 0.18% | 0.18% | 0.18% | Q2 2021 | Q2 2021 | 1 | |
| ARCT | ARCTURUS THERAPEUTICS ... | 1 | 1 | 0.17% | 0.17% | 0.17% | Q3 2021 | Q3 2021 | 1 |
| DSGN | Design Therapeutics Inc | 1 | 1 | 0.17% | 0.17% | 0.17% | Q4 2022 | Q4 2022 | 1 |
| AMYLYX PHARMACEUTICALS... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q1 2022 | Q1 2022 | 1 | |
| VIRX | VIRACTA THERAPEUTICS INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q1 2021 | Q1 2021 | 1 |
| COMPUGEN LTD | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2020 | Q4 2020 | 1 | |
| ARQT | ARCUTIS BIOTHERAPEUTIC... | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2020 | Q4 2020 | 1 |
| ADAGIO THERAPEUTICS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2021 | Q3 2021 | 1 | |
| PRTA | PROTHENA CORP PLC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q3 2022 | Q3 2022 | 1 |
| NCNA | NUCANA PLC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q3 2022 | Q3 2022 | 1 |
| FGEN | FibroGen Inc | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2023 | Q2 2023 | 1 |
| BDTX | BLACK DIAMOND THERAPEU... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2021 | Q1 2021 | 1 |
| Braze Inc | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2022 | Q4 2022 | 1 | |
| Acelyrin Inc | 1 | 1 | 0.07% | 0.07% | 0.07% | Q3 2023 | Q3 2023 | 1 | |
| ETON | ETON PHARMACEUTICALS INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2021 | Q2 2021 | 1 |
| CBIO | CATALYST BIOSCIENCES INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2021 | Q3 2021 | 1 |
| GKOS | Glaukos Corp | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2023 | Q2 2023 | 1 |
| PYPD | POLYPID LTD | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2022 | Q3 2022 | 1 |
| BNGOW | BIONANO GENOMICS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
| ACRS | Aclaris Therapeutics Inc | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2023 | Q3 2023 | 1 |
Download | |||||||||
The securities at the top of the list , including INTRA-CELLULAR THERAPIES INC, IMMUNOGEN INC, and Morphic Holding Inc, are the highest-conviction holdings of SILVERARC CAPITAL MANAGEMENT, LLC.
The conviction is calculated by counting the number of quarters a security has been reported by SILVERARC CAPITAL MANAGEMENT, LLC. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that SILVERARC CAPITAL MANAGEMENT, LLC owns currently or has owned in the past.